CLPT
Price
$14.25
Change
+$0.96 (+7.22%)
Updated
May 8 closing price
Capitalization
183.44M
4 days until earnings call
XAIR
Price
$0.19
Change
+$0.01 (+5.56%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
79.87M
54 days until earnings call
Ad is loading...

CLPT vs XAIR

Header iconCLPT vs XAIR Comparison
Open Charts CLPT vs XAIRBanner chart's image
ClearPoint Neuro
Price$14.25
Change+$0.96 (+7.22%)
Volume$349.59K
Capitalization183.44M
Beyond Air
Price$0.19
Change+$0.01 (+5.56%)
Volume$23.55K
Capitalization79.87M
CLPT vs XAIR Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. XAIR commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a StrongBuy and XAIR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (CLPT: $14.25 vs. XAIR: $0.19)
Brand notoriety: CLPT and XAIR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 141% vs. XAIR: 42%
Market capitalization -- CLPT: $183.44M vs. XAIR: $79.87M
CLPT [@Medical Specialties] is valued at $183.44M. XAIR’s [@Medical Specialties] market capitalization is $79.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 1 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 1 green, 4 red.
According to our system of comparison, CLPT is a better buy in the long-term than XAIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 7 TA indicator(s) are bullish while XAIR’s TA Score has 4 bullish TA indicator(s).

  • CLPT’s TA Score: 7 bullish, 4 bearish.
  • XAIR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CLPT is a better buy in the short-term than XAIR.

Price Growth

CLPT (@Medical Specialties) experienced а +2.44% price change this week, while XAIR (@Medical Specialties) price change was -11.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.37%. For the same industry, the average monthly price growth was +9.27%, and the average quarterly price growth was -3.44%.

Reported Earning Dates

CLPT is expected to report earnings on Aug 12, 2025.

XAIR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPT($183M) has a higher market cap than XAIR($79.9M). CLPT YTD gains are higher at: -7.347 vs. XAIR (-49.791). CLPT has higher annual earnings (EBITDA): -20.99M vs. XAIR (-67.06M). XAIR has more cash in the bank: 31.3M vs. CLPT (23.1M). CLPT has less debt than XAIR: CLPT (13.9M) vs XAIR (16.9M). CLPT has higher revenues than XAIR: CLPT (24M) vs XAIR (689K).
CLPTXAIRCLPT / XAIR
Capitalization183M79.9M229%
EBITDA-20.99M-67.06M31%
Gain YTD-7.347-49.79115%
P/E RatioN/AN/A-
Revenue24M689K3,483%
Total Cash23.1M31.3M74%
Total Debt13.9M16.9M82%
FUNDAMENTALS RATINGS
CLPT vs XAIR: Fundamental Ratings
CLPT
XAIR
OUTLOOK RATING
1..100
2350
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4095
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (30) in the null industry is in the same range as CLPT (53). This means that XAIR’s stock grew similarly to CLPT’s over the last 12 months.

CLPT's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for XAIR (100). This means that CLPT’s stock grew somewhat faster than XAIR’s over the last 12 months.

CLPT's SMR Rating (94) in the null industry is in the same range as XAIR (98). This means that CLPT’s stock grew similarly to XAIR’s over the last 12 months.

CLPT's Price Growth Rating (40) in the null industry is somewhat better than the same rating for XAIR (95). This means that CLPT’s stock grew somewhat faster than XAIR’s over the last 12 months.

CLPT's P/E Growth Rating (100) in the null industry is in the same range as XAIR (100). This means that CLPT’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTXAIR
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSIVX21.640.37
+1.74%
Janus Henderson Small Cap Value L
SRORX12.170.03
+0.25%
Calamos Antetokounmpo Sustainable Eqs R6
JIEZX20.94N/A
N/A
JPMorgan International Equity R2
SSQSX15.57N/A
N/A
State Street Instl Small-Cap Equity Svc
GSVPX15.33N/A
N/A
Goldman Sachs Small/Mid Cap Value P

CLPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPT
1D Price
Change %
CLPT100%
+7.22%
ICUI - CLPT
52%
Loosely correlated
+6.22%
ALGN - CLPT
44%
Loosely correlated
+5.06%
ISRG - CLPT
43%
Loosely correlated
+0.37%
HBIO - CLPT
41%
Loosely correlated
+1.53%
MMSI - CLPT
41%
Loosely correlated
+1.98%
More

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-9.59%
OPK - XAIR
35%
Loosely correlated
-2.34%
KIDS - XAIR
32%
Poorly correlated
+3.64%
SHWGY - XAIR
32%
Poorly correlated
N/A
CERS - XAIR
31%
Poorly correlated
+4.00%
IDXX - XAIR
31%
Poorly correlated
+2.72%
More